Pharmaceris Retinol 0.3% Anti-Acne Night Cream

The cream has a high concentration of 0.3% pure retinol that offers a balanced anti-wrinkle and anti-acne effect, restoring normal skin function during hormonal changes.
The encapsulation of retinol in ceramide microspheres ensures its stability and adequate protection from oxidation, effectively eliminating and preventing the recurrence of severe hormonal acne (papules, pimples, blemishes). Retinol restores homeostasis, reduces excessive sebum secretion and unblocks and shrinks pores,
It also has a very strong anti-wrinkle effect, forming anchoring fibrils between the epidermis and the dermis, reducing the depth, number and volume of wrinkles and fine lines.
When used regularly, the cream helps smooth and improve skin texture.
To ensure optimal skin comfort, the formula is enriched with moisturising and nourishing emollient ingredients (lily extract, shea butter, olive wax and cottonseed oil) and 4% biomimetic squalane that strengthens the lipid barrier of the epidermis.

Feature

Warnings

Product Specification

AQUA (WATER / EAU), HYDROGENATED POLYDECENE, GLYCERIN, PENTAERYTHRITYL TETRAISOSTEARATE, SQUALANE, CETEARYL ALCOHOL, BUTYROSPERMUM PARKII (SHEA) BUTTER, 1,2-HEXANEDIOL, GOSSYPIUM HERBACEUM (COTTON) SEED OIL, HYDROGENATED OLIVE OIL DECYL ESTERS, CETEARYL GLUCOSIDE, POTASSIUM CETYL PHOSPHATE, RETINOL, SODIUM POLYACRYLATE, HYDROXYACETOPHENONE, PENTYLENE GLYCOL, GLYCERYL BEHENATE, PARAFFIN, XANTHAN GUM, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, C10-18 TRIGLYCERIDES, TOCOPHERYL ACETATE, BHA, CERA ALBA (BEESWAX), STEARIC ACID, GLUCOSE, CERAMIDE NP, ETHYLHEXYLGLYCERIN, CLINTONIA BOREALIS (LILY) ROOT EXTRACT, BHT, PHENOXYETHANOL, PARFUM (FRAGRANCE).

Uses

Apply daily at night on clean face, neck and cleavage, avoiding contact with the eyes and mouth. During use, the product may cause temporary skin redness and flaking, which is a natural skin reaction. During the day, apply a minimum sunscreen protection of SPF 30. The preparation should not be used by pregnant women and patients who are currently taking oral retinoids.